Lowstar Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Telcon RF Pharmaceutical Co., Ltd.
MFDS item code 201904618 · Approved 2019.07.08
This product's status changed to Expired on 2024.07.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension who find it difficult to control blood pressure with either Amlodipine or Telmisartan alone.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Dose adjustment using the individual components (amlodipine or telmisartan) is recommended before administering this drug; however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults 75 years of age or older, clearance of amlodipine is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Administration of this drug is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious health problems for the fetus or newborn. This drug should not be administered to women with certain allergic reactions, pregnant women, nursing mothers, patients with severe liver dysfunction, or patients with very low blood pressure. Patients with primary aldosteronism, cardiac valve disease, impaired liver function, gastrointestinal disorders, and renal dysfunction need to exercise special caution when using this drug. Common side effects such as dizziness or peripheral edema may appear when taking this medication, and rare but serious side effects may also occur, so any abnormal symptoms should prompt immediate consultation with a doctor. Women who are pregnant or planning to become pregnant should be switched to other antihypertensive drugs with confirmed safety instead of this medication, and the use of this drug should be immediately discontinued upon confirmation of pregnancy. Patients who are dehydrated or have low salt levels should be especially careful as they may experience symptoms of hypotension, and where necessary, appropriate steps should be taken under a doctor's direction. This medication can increase serum potassium levels, hence when taken with potassium-containing supplements or other drugs, serum potassium levels should be monitored regularly through blood tests. Patients with impaired kidney function should have their kidney function and serum electrolyte levels regularly monitored while taking this drug. Patients with heart disease or heart failure should be carefully monitored as symptoms may worsen after taking this medication, and dosage adjustments may be necessary. This drug may interact with other medications that inhibit or induce certain enzymes, so it is essential to inform healthcare providers about any other medications being taken. Caution is advised when driving or operating hazardous machinery, as dizziness or drowsiness may occur during the use of this medication. In cases of overdose, symptoms such as low blood pressure, dizziness, and heart rhythm abnormalities may appear, requiring immediate medical treatment. This medication is not recommended for children or adolescents under 18 years of age due to insufficient evidence of safety and efficacy. For the elderly, dosage should be adjusted and increased gradually based on careful observation of the response to the medication. This drug should be kept out of reach of children, and it is best to store it in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is important to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its efficacy.
A white and light gray, double-layered, oval biconvex tablet.
30 tablets / PTP [10 tablets / PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Telcon RF Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.